Instituto Grifols, S.a.
Clinical trials sponsored by Instituto Grifols, S.a., explained in plain language.
-
Blood filtering treatment tested for sudden liver failure
Disease control TerminatedThis study tested a blood filtering procedure called plasma exchange using a 5% albumin solution in people with acute-on-chronic liver failure (ACLF), a sudden worsening of chronic liver disease. The trial enrolled 274 high-risk patients across the US, Canada, and Europe, compari…
Phase: PHASE3 • Sponsor: Instituto Grifols, S.A. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Polio Survivors' hope dashed: trial of immune treatment halted early
Disease control TerminatedThis study tested a blood product called immune globulin (Flebogamma) in 191 people with post-polio syndrome, a condition causing new muscle weakness years after polio. The goal was to see if it could improve walking distance and reduce pain. The trial was terminated early, so we…
Phase: PHASE2, PHASE3 • Sponsor: Instituto Grifols, S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC